TY - JOUR
T1 - Rate of palivizumab administration in accordance with current recommendations among hospitalized children
AU - Moynihan, James A.
AU - Kim, Tommy
AU - Young, Tammy
AU - Checchia, Paul A.
N1 - Exact barriers to the administration of palivizumab remain unclear. The identification of high-risk children, prevention of RSV by use of palivizumab, and collaboration between hospital and community health care providers will help increase the use of palivizumab and decrease the incidence of RSV.
PY - 2004/9/1
Y1 - 2004/9/1
KW - Respiratory Syncytial Virus Infections/drug therapy
KW - Guideline Adherence/statistics & numerical data
KW - Pediatrics/standards
KW - Humans
KW - Clinical Protocols
KW - Antibodies, Monoclonal/therapeutic use
KW - Infant
KW - California
KW - Drug Utilization Review
KW - Antibodies, Monoclonal, Humanized
KW - Palivizumab
KW - Antiviral Agents/therapeutic use
KW - Hospitalization/statistics & numerical data
KW - Retrospective Studies
UR - http://www.ncbi.nlm.nih.gov/pubmed/15337916
UR - https://www.mendeley.com/catalogue/ce0502d3-cb72-323e-8a78-4466885e51ff/
UR - https://www.scopus.com/pages/publications/4344580998
UR - https://www.scopus.com/pages/publications/4344580998#tab=citedBy
U2 - 10.1016/J.PEDHC.2004.02.006
DO - 10.1016/J.PEDHC.2004.02.006
M3 - Article
C2 - 15337916
SN - 0891-5245
VL - 18
SP - 224
EP - 227
JO - Journal of Pediatric Health Care
JF - Journal of Pediatric Health Care
IS - 5
ER -